|
|
|
|
Researchers Find New Actions of Neurochemicals
ELEGANS, WORM, CHLORIDE CHANNELS, DOPAMINE, BIOGENIC AMINES, DEPRESSION, SCHIZOPHRENIA Contact Information Available for logged-in reporters only Description Although the tiny roundworm Caenorhabditis elegans has only 302 neurons in...
|
|
|
[Report] Ligand-Gated Chloride Channels Are Receptors for Biogenic Amines in C. elegans
_ [Report] Ligand-Gated Chloride Channels Are Receptors for Biogenic Amines in C.elegans.
|
|
|
Is Dow Ag Still Up for Sale?
I thought we had put this to bed but this little item in the caught my attention: China National Chemical Corp, the mainland's largest chemicals maker, has returned to the bidders' table after Dow Chemical (DOW) restarted an auction for its...
|
|
|
Fresenius Medical Care receives FDA approval to manufacture saline in Mexico for US dialysis market
Fresenius Medical Care North America (FMCNA) (Frankfurt:FME), which supplies products and services for dialysis patients, announced on Thursday that its manufacturing facility in Guadalajara, Mexico, has received US regulatory approval to...
|
|
|
Fresenius Medical Care to Manufacture Saline for U.S. Dialysis Market in Mexico
WALTHAM, Mass.- (BUSINESS WIRE) - Fresenius Medical Care North America's (FMCNA) manufacturing facility in Guadalajara, Mexico, received regulatory approval by the U.S. Food and Drug Administration (FDA) to manufacture and distribute...
|
|
|
Fresenius Medical Care to Manufacture Saline for U.S. Dialysis Market in Mexico
- Fresenius Medical Care North Americas (FMCNA) manufacturing facility in Guadalajara, Mexico, received regulatory approval by the U.S.Food and Drug Administration (FDA) to manufacture and distribute saline solution (0.9% Sodium ...
|
|
|
Fresenius Medical Care to Manufacture Saline for U.S. Dialysis Market in Mexico
Fresenius Medical Care North Americas (FMCNA) manufacturing facility in Guadalajara, Mexico, received regulatory approval by the U.S.Food and Drug Administration (FDA) to manufacture and distribute saline solution (0.9% Sodium ...
|
|
|
Fresenius Medical Care to Manufacture Saline for U.S. Dialysis Market in Mexico
Fresenius Medical Care North Americas (FMCNA) manufacturing facility in Guadalajara, Mexico, received regulatory approval by the U.S.Food and Drug Administration (FDA) to manufacture and distribute saline solution (0.9% Sodium ...
|
|
|
Fresenius Medical Care to Manufacture Saline for U.S. Dialysis Market in
Fresenius Medical Care North Americas (FMCNA) manufacturing facility in Guadalajara, Mexico, received regulatory approval by the U.S.Food and Drug Administration (FDA) to manufacture and distribute saline solution (0.9% Sodium ...
|
|
|
Fresenius Medical Care to Manufacture Saline for U.S. Dialysis Market in Mexico
BusinessWire - Fresenius Medical Care North America's (FMCNA) manufacturing facility in Guadalajara, Mexico, received regulatory approval by the U.S.Food and Drug Administration (FDA) to manufacture and distribute saline solution (0.9% ...
|
|
|
Fresenius Medical Care to Manufacture Saline for U.S. Dialysis Market in Mexico
Fresenius Medical Care North Americas (FMCNA) manufacturing facility in Guadalajara, Mexico, received regulatory approval by the U.S.Food and Drug Administration (FDA) to manufacture and distribute saline solution (0.9% Sodium ...
|
|
|
Fresenius Medical Care to Manufacture Saline for U.S. Dialysis Market in Mexico
WALTHAM, Mass.--(BUSINESS WIRE)-- Fresenius Medical Care North America's (FMCNA) manufacturing facility in Guadalajara, Mexico, received regulatory approval by the U.S.Food and Drug Administration (FDA) to manufacture and distribute...
|
|
|
Fresenius Medical Care to Manufacture Saline for U.S. Dialysis Market in Mexico
WALTHAM, Mass.--(BUSINESS WIRE)--Fresenius Medical Care North Americas (FMCNA) manufacturing facility in Guadalajara, Mexico, received regulatory approval by the U.S.Food and Drug Administration (FDA) to manufacture and distribute saline...
|
|
|
Fresenius Medical Care to Manufacture Saline for U.S. Dialysis
Fresenius Medical Care North Americas (FMCNA) manufacturing facility in Guadalajara, Mexico, received regulatory approval by the U.S.Food and Drug Administration (FDA) to manufacture and distribute saline solution (0.9% Sodium ...
|
|
|
Fresenius Medical Care to Manufacture Saline for U.S. Dialysis Market in Mexico
Fresenius Medical Care North America's (FMCNA) manufacturing facility in Guadalajara, Mexico, received regulatory approval by the U.S.Food and Drug Administration (FDA) to manufacture and distribute saline solution (0.9% Sodium ...
|
|
|
Fresenius Medical Care to Manufacture Saline for U.S. Dialysis Market in Mexico
WALTHAM, Mass.--(BUSINESS WIRE)--Fresenius Medical Care North Americas (FMCNA) manufacturing facility in Guadalajara, Mexico, received regulatory approval by the U.S.Food and Drug Administration (FDA) to manufacture and distribute saline...
|
|
|
Controlling the Genotoxins Ethyl Chloride and Methyl Chloride Formed During the Preparation of Amine Hydrochlo
Chemical Development and Analytical and Quality Services, AMRI, P.O.Box 15098, Albany, New York 12212-5098, U.S.A., Memory Pharmaceuticals Corp., 100 Phillips Parkway, Montvale, New Jersey 07645, U.S.A., Roche Palo Alto, LLC, 3431...
|
|
|
IOL Chemicals fit Pharmaceuticals all set to emerge as India''s largest Ibuprofen manufacturer
IOL Chemicals and Pharmaceuticals Limited (IOLCP) has announced the commencement of its manufacturing operations of Mono-chloro Acetic Acid (MCA) and Acetyl Chloride at its new manufacturing units with capacities of 7200 TPA and 5200...
|
|
|
Dow To Raise $900m From Divestment
Dow Chemical has announced that it has signed two separate sale agreement totaling in excess of $900m as part of its de-leveraging plan designed to pay down debt, preserve financial flexibility, streamline its portfolio and improve cash flow...
|
|
|
Salix Pharmaceuticals to Present at Bank of America and Merrill Lynch Conference
RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd.(NASDAQ:SLXP - News) today announced that the Company will present at the Bank of America and Merrill Lynch 2009 Health Care Conference in New York, NY on Tuesday, May 12 at 10:40...
|
|
|
Salix Pharmaceuticals Announces 1Q2009 Financial Results Conference Call and Webcast
RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd.(NASDAQ:SLXP - News) today announced that the Company will report first quarter 2009 financial results following the close of the U.S. financial markets on Tuesday, May 5, 2009....
|
|
|
Salix Pharmaceuticals Announces 1Q2009 Financial Results Conference Call and Webcast
Company Website: http:www.salix.comRALEIGH, N.C.-- (Business Wire) Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will report first quarter 2009 financial results following the close of the U.S. financial...
|
